Literature DB >> 19884731

Rhinosporidiosis of parotid duct.

B Sivapathasundharam1, T R Saraswathi, K Manjunath, G Sriram.   

Abstract

Rhinosporidiosis is a benign chronic granulomatous infection caused by Rhinosporidium seeberi. Rhinosporidiosis is endemic in south Asia, notably in southern India and Sri Lanka. Majority of the cases have been reported to occur in upper respiratory sites, notably anterior nares, nasal cavity, nasopharynx, larynx and soft palate. Only two rare cases of involvement of parotid duct, have been reported in literature. Hence, this case will probably be the third to be reported.

Entities:  

Mesh:

Year:  2009        PMID: 19884731     DOI: 10.4103/0970-9290.57362

Source DB:  PubMed          Journal:  Indian J Dent Res        ISSN: 0970-9290


  5 in total

1.  A Rare Presentation of Rhinosporidiosis.

Authors:  Joseph Williams; Nitin M Nagarkar; Rupa Metha; Satish Satpute; Amit Bugalia
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-02-07

2.  Rhinosporidiosis isolated to the distal clavicle: a rare presentation clinicoradiologically mimicking a bone tumor.

Authors:  Pallavi Vishnu Suryawanshi; Bharat Rekhi; Saral Desai; Subhash M Desai; Shashi L Juvekar; Nirmala Ajit Jambhekar
Journal:  Skeletal Radiol       Date:  2010-08-11       Impact factor: 2.199

3.  Two rare cases of rhinosporidiosis of parotid duct: Case reports and review of literature.

Authors:  Mounabati Mohapatra; C S Banushree
Journal:  Ann Maxillofac Surg       Date:  2014 Jul-Dec

4.  Rhinosporidiosis of Parotid Duct Presenting as Consecutive Bilateral Facial Swelling: A Rare Case Report and Literature Review.

Authors:  Santanu Sarkar; Soumyajyoti Panja; Arghya Bandyopadhyay; Shreosee Roy; Sandeep Kumar
Journal:  J Clin Diagn Res       Date:  2016-03-01

5.  Evaluation of diagnosed cases of eye rhinosporidiosis in a public hospital of Maranhão, Northeast Brazil.

Authors:  Francílio Araújo Almeida; Antonio Augusto Lima Teixeira-Junior; Jaqueline Diniz Pinho; Elaine Fiod Costa; Gyl Eanes Barros Silva
Journal:  BMC Ophthalmol       Date:  2019-11-08       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.